Market Cap 4.72M
Revenue (ttm) 7.01M
Net Income (ttm) -3.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -43.94%
Debt to Equity Ratio 0.38
Volume 202,378
Avg Vol 885,634
Day's Range N/A - N/A
Shares Out 19.25M
Stochastic %K 21%
Beta 0.76
Analysts Strong Buy
Price Target $4.50

Latest News on CPHI

China Pharma to Launch Highly Purified NMN+PQQ Product

Jun 9, 2021, 8:00 AM EDT - 4 years ago

China Pharma to Launch Highly Purified NMN+PQQ Product